Terapia indolore e non invasiva
per il cancro della pelle

Rhenium-SCT®

Bringing back Quality of Life

Non invasiva
Indolore
Unica seduta

Hai bisogno di un appuntamento?

E' stata cambiata o posticipata la data del tuo trattamento per il cancro della pelle a causa del COVID-19?

Con il Programma di riferimento Rhenium-SCT vi mettiamo in contatto diretto con il centro di trattamento più vicino.

Programma di riferimento Rhenium-SCT:

richiedi qui la prossima data disponibile per il trattamento.

Rhenium-SCT®

Non invasiva
Indolore
Estetica

La Rhenium-SCT (Skin Cancer Therapy) è una brachiterapia specializzata d’avanguardia che utilizza il radioisotopo Rhenium-188, un beta-emettitore che in questo caso viene utilizzato per il trattamento dei carcinomi basali e squamosi della pelle.

188W/188Re Generatori

produzione di 188Re ad alta emissione di energia.

Varie dimensioni disponibili

fino a 150GBq (4Ci) (4Ci) 188W

Alta concentrazione di attività

fino a 9GBq/ml

Volume di eluizione variabile

Volume di eluizione di 5-14 ml (eluizione parziale per piccoli volumi)

Bassa penetrazione

188W < 0.01 % rispetto a 188Re al momento della calibrazione

Chi siamo

OncoBeta GmbH è un pioniere nel settore dei radioisotopi, che attualmente offre una terapia innovativa per la cura del cancro della pelle che si rivolge ai tumori della pelle non melanoma e produce generatori di Tungsteno (Wolfram)-188/Renio-188 (W/Re-188) per uso commerciale.

Recent Events

COVID-19: We are here for you.

To our Valued Patients, Customers and Health Care providers, As we navigate through these trying times surrounding the Coronavirus (COVID-19)...
Read More

China Isotope & Radiation Corporation (CIRC) and OncoBeta sign distribution agreement for Tungsten 188/Rhenium-188 generators

Tuesday 30th June 2020 Beijing, China and Garching near Munich, Germany, Tuesday 30th June 2020. CIRC and OncoBeta today announced...
Read More

B.J. Madan & Co India and OncoBeta announce exclusive distribution agreement for W/Re-188 generators.

New Delhi, India and Garching near Munich, Germany, 6th March, 2020. B.J Madan & Co and OncoBeta announced the execution...
Read More

RadioMedix and OncoBeta announce exclusive distribution agreement for W/Re-188 generators in U.S. and Canada.

Houston, TX, USA and OncoBeta GmbH, Garching/, Germany, February 7th, 2020 RadioMedix and OncoBeta today announced the execution of an...
Read More

Oncobeta chosen as one of the Trailblazing Companies to Watch in 2019

OncoBeta- A Pioneer And Innovator In The Epidermal Radioisotope Therapy Sector Skin is the largest organ of the body and...
Read More

First non-melanoma skin cancer patients treated with the Rhenium-SCT® in Germany

– The first Rhenium-SCT® treatment was accomplished by the interregional professional association for nuclear medicine in Hanau October 4, 2019;...
Read More

OncoBeta® chosen as a 2019 Red Herring North America Top 100 Winner

New recognition of OncoBeta’s success in developing and providing an innovative therapy for non-melanoma skin cancer patients. July 5, 2019;...
Read More

Rhenium-SCT® (SCT= Skin Cancer Therapy) now being offered in Hanau, Germany

May 13 2019, Garching n. Munich, Germany– OncoBeta® GmbH, a commercial stage Medical Device Company specialized in innovative epidermal radioisotope...
Read More

OncoBeta ® GmbH Named Among ‘30 Ethical Companies of the Year 2019’ by The Silicon Review Magazine

Recognition for OncoBeta`s mission to give non-melanocytic skin cancer patients back their quality of life. April 05, 2019; Garching near...
Read More

OncoBeta® chosen as a 2019 Red Herring Top 100 Europe Winner

Recognition of OncoBeta’s success in developing and providing an innovative therapy for patients suffering from non-melanocytic skin cancer Feb 20,...
Read More